FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283821597> ?p ?o ?g. }

• W4283821597 abstract "Background Although atrial fibrillation (AF) is a risk factor for ischemic bowel disease, data regarding the incidence of ischemic bowel disease in patients with anticoagulated AF were limited. Methods The present study used the Taiwan NHIRD and included newly diagnosed patients with AF aged ≥ 20 years without ischemic bowel disease from 2012 to 2018. A total of 69,549 patients taking warfarin or non-vitamin K antagonist oral anticoagulants (NOACs) constituted the final study group. We aimed to study the incidence of ischemic bowel disease in patients with AF receiving warfarin or NOACs. Secondary endpoints were also analyzed, including ischemic stroke, systemic embolism, myocardial infarction, mortality, intracranial hemorrhage (ICH), major bleeding, and composite adverse events (ischemic bowel disease or ICH or major bleeding). Results There were 43,787 patients taking NOACs and 25,762 patients taking warfarin. The overall incidence rate of ischemic bowel disease was 0.036% per year and increased with the CHA 2 DS 2 -VASc scores [0.013% for patients with a CHA 2 DS 2 -VASc score of 0 (men) or 1 (women), 0.022% for those with a CHA 2 DS 2 -VASc score of 1 (men) or 2 (women), and 0.039% for those with a CHA 2 DS 2 -VASc score ≥ 2 (men) or ≥ 3 (women)]. The risk of ischemic bowel disease was similar between NOAC and warfarin groups (0.036%/year vs. 0.037%/year; adjusted hazard ratio 0.802, p = 0.430), whereas the NOAC group had a significantly lower risk of secondary endpoints compared to the warfarin group. Conclusion We reported the incidence of ischemic bowel disease in patients with anticoagulated AF from a nationwide cohort database and observed a positive correlation between the increase of CHA 2 DS 2 -VASc scores and the incidence rate. Moreover, NOAC was as effective as warfarin for the risk of ischemic bowel disease." @default.
• W4283821597 created "2022-07-06" @default.
• W4283821597 creator A5003158130 @default.
• W4283821597 creator A5012432326 @default.
• W4283821597 creator A5033867132 @default.
• W4283821597 creator A5039065235 @default.
• W4283821597 creator A5069412202 @default.
• W4283821597 creator A5078644351 @default.
• W4283821597 date "2022-07-05" @default.
• W4283821597 modified "2023-10-18" @default.
• W4283821597 title "Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants" @default.
• W4283821597 cites W1543698101 @default.
• W4283821597 cites W1854805108 @default.
• W4283821597 cites W2023373412 @default.
• W4283821597 cites W2042265219 @default.
• W4283821597 cites W2045982028 @default.
• W4283821597 cites W2079684506 @default.
• W4283821597 cites W2096246254 @default.
• W4283821597 cites W2097854437 @default.
• W4283821597 cites W2121010946 @default.
• W4283821597 cites W2127985968 @default.
• W4283821597 cites W2136489990 @default.
• W4283821597 cites W2147715732 @default.
• W4283821597 cites W2152623033 @default.
• W4283821597 cites W2162508946 @default.
• W4283821597 cites W2162586165 @default.
• W4283821597 cites W2163337909 @default.
• W4283821597 cites W2263274730 @default.
• W4283821597 cites W2346658271 @default.
• W4283821597 cites W2589649501 @default.
• W4283821597 cites W2742337206 @default.
• W4283821597 cites W2761532891 @default.
• W4283821597 cites W2774842899 @default.
• W4283821597 cites W2790204922 @default.
• W4283821597 cites W2895625139 @default.
• W4283821597 cites W2907331886 @default.
• W4283821597 cites W2944205814 @default.
• W4283821597 cites W3029757349 @default.
• W4283821597 cites W3119721107 @default.
• W4283821597 cites W3132713481 @default.
• W4283821597 cites W3133704645 @default.
• W4283821597 cites W3185694652 @default.
• W4283821597 cites W3188945873 @default.
• W4283821597 cites W3208723599 @default.
• W4283821597 cites W3213637563 @default.
• W4283821597 cites W3214524979 @default.
• W4283821597 cites W4206470140 @default.
• W4283821597 cites W4220884194 @default.
• W4283821597 cites W4237821768 @default.
• W4283821597 cites W4251799071 @default.
• W4283821597 doi "https://doi.org/10.3389/fcvm.2022.874460" @default.
• W4283821597 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35865380" @default.
• W4283821597 hasPublicationYear "2022" @default.
• W4283821597 type Work @default.
• W4283821597 citedByCount "1" @default.
• W4283821597 countsByYear W42838215972022 @default.
• W4283821597 crossrefType "journal-article" @default.
• W4283821597 hasAuthorship W4283821597A5003158130 @default.
• W4283821597 hasAuthorship W4283821597A5012432326 @default.
• W4283821597 hasAuthorship W4283821597A5033867132 @default.
• W4283821597 hasAuthorship W4283821597A5039065235 @default.
• W4283821597 hasAuthorship W4283821597A5069412202 @default.
• W4283821597 hasAuthorship W4283821597A5078644351 @default.
• W4283821597 hasBestOaLocation W42838215971 @default.
• W4283821597 hasConcept C120665830 @default.
• W4283821597 hasConcept C121332964 @default.
• W4283821597 hasConcept C126322002 @default.
• W4283821597 hasConcept C127413603 @default.
• W4283821597 hasConcept C164705383 @default.
• W4283821597 hasConcept C207103383 @default.
• W4283821597 hasConcept C2776301958 @default.
• W4283821597 hasConcept C2776704044 @default.
• W4283821597 hasConcept C2779161974 @default.
• W4283821597 hasConcept C2780645631 @default.
• W4283821597 hasConcept C44249647 @default.
• W4283821597 hasConcept C61511704 @default.
• W4283821597 hasConcept C71924100 @default.
• W4283821597 hasConcept C78519656 @default.
• W4283821597 hasConcept C90924648 @default.
• W4283821597 hasConceptScore W4283821597C120665830 @default.
• W4283821597 hasConceptScore W4283821597C121332964 @default.
• W4283821597 hasConceptScore W4283821597C126322002 @default.
• W4283821597 hasConceptScore W4283821597C127413603 @default.
• W4283821597 hasConceptScore W4283821597C164705383 @default.
• W4283821597 hasConceptScore W4283821597C207103383 @default.
• W4283821597 hasConceptScore W4283821597C2776301958 @default.
• W4283821597 hasConceptScore W4283821597C2776704044 @default.
• W4283821597 hasConceptScore W4283821597C2779161974 @default.
• W4283821597 hasConceptScore W4283821597C2780645631 @default.
• W4283821597 hasConceptScore W4283821597C44249647 @default.
• W4283821597 hasConceptScore W4283821597C61511704 @default.
• W4283821597 hasConceptScore W4283821597C71924100 @default.
• W4283821597 hasConceptScore W4283821597C78519656 @default.
• W4283821597 hasConceptScore W4283821597C90924648 @default.
• W4283821597 hasFunder F4320323441 @default.
• W4283821597 hasLocation W42838215971 @default.
• W4283821597 hasLocation W42838215972 @default.
• W4283821597 hasLocation W42838215973 @default.
• W4283821597 hasOpenAccess W4283821597 @default.
• W4283821597 hasPrimaryLocation W42838215971 @default.

• next